The results revealed that SRC mRNA level was significantly upregulated in primary tumor tissues compared in normal tissues, and the TNBC patients showed overall higher SRC expression than the other BC subtypes, including Luminal and HER2 + subtypes (Fig. 1A–B). The gene discussed is ERBB2; the disease is breast cancer.